Phase 1 1 First-In-Human study designed to assess safety , tolerability , right dose for Phase 2 and early signs of efficacy of 177Lu-RAD20 2 in individuals with advanced HER2-positive solid tumors Previous clinical proof-of concept data 2 for targeting HER-2 demonstrated…
West High Yield (W.H.Y.) Resources Ltd. (TSXV: WHY) (FSE: W0H) (the ‘Company’ or ‘West High Yield’) announces announces the…
Canadian wildfires are hitting Manitoba hard, triggering the evacuation of over 17,000 people in province. “This is the largest…
Edward Sterck, director of research at the World Platinum Investment Council, reviews the organization’s latest quarterly report, honing in…
International Graphite (IG6:AU) has announced Development update – Collie graphite micronising facility Download the PDF here. This post appeared…
Global uranium production has experienced significant fluctuations over the past decade. After peaking at 63,207 metric tons in 2016,…
(TheNewswire) Brossard (Québec) TheNewswire – le 3 juin 2025 — CORPORATION CHARBONE HYDROGÈNE (TSXV: CH OTCQB: CHHYF, FSE: K47…
